Large-scale population studies demonstrate an association between mothers' deaths and child mortality in both lower and higher income countries. The authors estimated children's deaths in association with mothers' deaths from breast or cervical cancer, 2 common cancers in low-income and middle-income countries affecting women of reproductive age, to develop a comprehensive assessment of the death burden of these cancers. METHODS: A Monte Carlo simulation model was devised whereby women were at risk of dying from breast cancer, cervical cancer, or another cause. Compared with children who have living mothers, children of women who die before they reached age 10 years have an elevated risk of death from all causes. Therefore, simulations were conducted, and the impact of mothers' deaths from cervical and breast cancer on associated child mortality was quantified for Bangladesh, Burkina Faso, and Denmark (benchmark analysis), then the analyses were extended to all African countries. RESULTS: Benchmark estimates of child deaths associated with mothers' deaths from breast and cervical cancer resulted in an increment in cancer-related mortality of approximately 2% in Bangladesh, 14% in Burkina Faso, and less than 1% in Denmark. The model predicted an increment in comprehensive cancer deaths when including child death estimates by as high as 30% in certain African countries. CONCLUSIONS: To the authors' knowledge, this is the first study to estimate the impact of a mother's death from cancer on child mortality. The model's estimates call for further investigation into this correlation and underscore the relevance of adequate access to prevention and treatment among women of childbearing age. Cancer 2019;125:109-117.
INTRODUCTION
The third goal of the United Nations Sustainable Development Goals (SDGs) is to promote well being and ensure healthy lives for all at all ages. 1 Reflections after the announcement of the SDGs included criticism of the limited progress made on the previous Millennium Development Goals (MDGs) seeking to improve maternal health and have called for greater attention to more sex-sensitive approaches to sustainability. 2 In particular, the fourth and fifth targets of the United Nations MDGs had been to reduce child mortality and improve maternal health. 3, 4 Likewise, the SDGs call for greater action to address the tsunami of noncommunicable diseases (NCDs), including cancer, setting a goal by 2030 to reduce premature mortality from NCDs by one-third through prevention and treatment. 1 Traditionally, interventions aimed at reducing child mortality focused on reducing diarrhea, measles, malaria, malnutrition, and acute respiratory infections, because these 5 factors account for the majority of infant and child deaths. 5 Consistent with this, a prospective population cohort study involving 150,000 live births in Bangladesh demonstrated that nutritional deficiency, diarrheal illness, and respiratory infections were the key factors responsible for child deaths. 6 A novel finding of that cohort study was its demonstration that a mother's death from any cause, before the child reached age 10 years, was significantly associated with increased child mortality. Other prospective cohort studies in Asia, Africa, and Europe have confirmed a statistically significant association between maternal and child mortality (Table 1) . [6] [7] [8] [9] [10] Li et al describe this association until the child reaches age 18 years in Denmark and Sweden, 2 countries with similar publically financed national health systems. 7 That this correlation has been described in low-income and high-income countries alike suggests the global nature of this phenomenon. However, the strength of this association appears to differ between countries, [6] [7] [8] [9] [10] and most studies are limited to particular causes of death or to a limited age range (ie, infancy and early childhood).
Cancer January 1, 2019 For the current report, we examined the impact of breast and cervical cancer, 2 major causes of death globally that particularly afflict women of childbearing age. 11 We chose cancer because "neoplasm" accounted for the highest contributor to mortality for women ages 15 to 49 years globally from 1990 to 2016. 12 Breast and cervical cancer account for approximately 40% of all cancer deaths globally among women ages 15 to 49 years. 11 Breast cancer represents a leading cause of cancer-related mortality in most countries worldwide and was responsible for 14% of all female cancer deaths in 2012. 13 Furthermore, breast cancer incidence rates are on the increase in many countries undergoing social and economic transition, in part because of changing reproductive patterns and rising rates of overweight and obesity.
14 Globally, 80% of cervical cancers occur in the developing world, and the majority of the annual 275,000 deaths occur in those geographic areas. [15] [16] [17] Cervical cancer mortality rates tend to be in decline in most countries that have established databases on cancer incidence or mortality, a change that has been hastened in high-income countries by effective screening programs. In contrast, within Sub-Saharan Africa, there are increasing incidence rates recorded in Uganda and Zimbabwe. 18, 19 In the current study, we propose a model with which to quantify the impact of mothers' deaths from breast or cervical cancer on subsequent child deaths.
MATERIALS AND METHODS
We devised a Monte Carlo simulation model to quantify the impact of the deaths of mothers from breast or cervical cancer on childhood survival. A schematic of the model is provided in Figure 1 . A detailed description of the model, along with its assumptions and validation, is provided in the Supporting Materials. A model simulation was run for 1 million women separately for each country in the analysis. The model started with women entering at age 15 years and having a possibility of giving birth every year until age 50 years 20 (the average age for menopause). 21 The model tracked the outcome of all offspring. Apart from the chance of giving birth, the model simulated women's risk of death from either cervical cancer, breast cancer, or another cause. 11, 22 If a woman died from cervical or breast cancer, then the final phase of the model simulation was applied (Fig. 1, right) , and her children were at increased risk of death and were tracked until age 10 years.
A child's risk of death was derived from the baseline country-specific, all-cause mortality rate per 100,000 children born, as reported by the United Nations World Population Prospects, multiplied by the excess mortality rate ratio (EMRR). 22 The EMRR is a multiplier of how much higher the rate of dying is for a child whose mother has died compared with a child whose mother is alive in the same population. Table 1 demonstrates how the EMRR varies across countries. On the basis of country-specific data, EMRRs from 0.5 to 9.0 were tested in the model. For example, an EMRR value of 0.5 would indicate that a child of a mother who died would have a 50% higher rate of all-cause mortality than a child whose mother had not died; an EMRR value of 9.0 means that a child of a mother who died would have a 900% higher rate of all-cause mortality than a child whose mother did not die. The model was constructed using the TreeAge software platform (TreeAge Software Inc, Williamstown, MA). 23 We defined 2 outcomes for the model: an absolute measure and a relative measure of the contributions to child mortality derived from mothers' deaths because of breast and cervical cancer. The absolute mortality contribution (AMC) represents the number of estimated child deaths associated with mothers' deaths from breast and cervical cancer in a specific country and is calculated using standardized model simulations of 1 million women. We chose standardization to facilitate comparisons across nations. For example, by standardizing The excess mortality rate ratio is a multiplier of how much higher the rate of dying is for a child whose mother has died compared with a child whose mother is alive in the same population. b Because this was a case-control study, the value here is an odds ratio.
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and comparing country A versus country B, the country with the higher absolute contribution in associated deaths is experiencing a greater burden associated with mothers' deaths from breast and cervical cancer.
The relative mortality contribution (RMC) defines the contribution to children's risk of dying before age 10 years from mothers' deaths because of cervical and breast cancer and is a metric designed to capture the comprehensive burden of cervical and breast cancer. A country's life tables and mortality rate databases for children already capture children who have died in association with their mothers' deaths. The objective of our model is to define the contribution of mothers' breast and cervical cancer deaths to children's deaths, enabling us to estimate the comprehensive burden of women's cancers when including associated child deaths.
Therefore, the RMC reflects the percentage increase of overall cervical and cancer deaths when accounting for child deaths consequent to mothers' deaths. For example, an RMC value of 2% means that, for every 100 women who die from breast or cervical cancer in the model, an estimated 2 children will because of their mother's death from these cancers. Whereas the absolute metric is useful for comparing the burden across borders, the relative metric allows for a within-country, comprehensive evaluation of disease burden by including associated child deaths when quantifying maternal mortality from breast and cervical cancer.
Benchmark Analysis
Three benchmarking countries-Denmark, Bangladesh, and Burkina Faso-served to estimate the impact of a woman's death from cervical and breast cancer on child mortality. These 3 were selected because of their different resource levels and geographic representations. In addition, all model parameters were available for these nations: population-level fertility, cancer mortality, adult mortality, child mortality, and, importantly, the EMRR ( Table 1 ). The EMRR for Burkina Faso was estimated from a cohort study that tracked until children until age 5 years, as opposed to age 10 years for the other benchmarking nations. 10 Because these children were not followed until age 10 years, we ran 1 set of analyses in which the model terminated 5 years earlier than in Bangladesh or Denmark.
Sensitivity Analysis
To understand the correlation between input factors and outcomes, we performed a sensitivity analysis on the base-case countries to generate tornado plots and demonstrate the influence of these variables on the outcomes of AMC and RMC. A description of the methodology for completing the sensitivity analysis is provided in Supporting Table 1 .
Extended Analysis
Next, we estimated the impact of women's deaths from breast and cervical cancer on children's deaths for all African countries. In contrast to the benchmark countries, in which the EMRR has been defined, populationspecific EMRRs have not been defined for many African nations. This lack of data prompted us to perform simulation analysis at defined EMRR values of 0.5, 3.0, 6.0, and 9.0 to capture the range of values obtained from the studies by Li et al and Ronsmans and colleagues. 6, 7 
RESULTS

Benchmark Analysis
The model used EMRRs as multipliers to capture how much higher the rate of dying is for a child whose mother has died, compared with a child whose mother is alive, in the same country. Model simulations for Denmark, Burkina Faso, and Bangladesh used EMRR values of 0.5, 6.0, and 9.0, respectively, so that, for the benchmark analyses, children of mothers who died from breast or cervical cancer experienced mortality rates that were from 0.5 to 9.0 times higher than the baseline rates. Parameters including country-specific fertility rates and child mortality rates, alongside the absolute and relative mortality outcomes, are displayed in Table 2 .
Given relatively low fertility rates, low cervical cancer mortality, and low child mortality, the impact of women's deaths from breast and cervical cancer on children's deaths in Denmark contributed only 1 child death for 6473 maternal deaths. For Burkina Faso, with model termination 5 years earlier than in Denmark and Bangladesh, the estimated RMC was 14%. We then ran simulations for Burkina Faso, where children were tracked as long as in Denmark and Bangladesh, which resulted in an RMC of 16%. Although it had the highest EMRR value among the benchmarking nations, Bangladesh had child mortality rates lower compared with those in Burkina Faso; as a result, Bangladesh was estimated to have an RMC of approximately 2%.
Sensitivity Analysis
With Denmark's low rates of cervical cancer mortality, fertility, EMRR, and child mortality, its outcomes reflected little influence to variations in informing parameters. More substantial are the analyses of Burkina Faso and Bangladesh were more substantial, as indicated by the tornado plots provided in Figure 2A -D (also see Supporting Table 2 ). The outcome of AMC was much more sensitive to changes in variables than RMC for both Bangladesh and Burkina Faso. For Bangladesh, the RMC remained between 1.1% and 2.4% across analyses, with variation of all parameters, and the most influential parameters were child mortality and breast cancer mortality. For Burkina Faso's sensitivity analysis (which tracked children until age 5 years), in all but 1 case, the RMC remained between 12.1% and 16.3%. Sensitivity analysis of the EMRR noted variability in the AMC from 201 to 2121 and in the RMC from 1.76% to 25.1%.
Extended Analysis to All African Countries
The 10 African countries with the highest number of female deaths from breast and cervical cancer, the highest fertility, and the highest baseline child mortality are listed in Table 3 . The 10 African nations with the highest predicted absolute and relative contributions to cervical and breast cancer mortality when including associated child mortality are presented in Table 4 . Table 3 indicates all 6 countries that ranked in the top 10 for more than 1 category (cancer deaths, fertility, or baseline child mortality) ranked in the top 10 for either AMC or RMC. Mali and Burundi are present on the top 10 across all 3 categories. Somalia is among Africa's highest 10 for both fertility and maternal deaths from breast or cervical cancer; and Chad, Angola, and the Democratic Republic of the Congo appear on both lists for fertility and baseline child mortality. The AMC and RMC results for all 53 Cancer January 1, 2019 African countries across the 4 levels of EMRR are provided in Supporting Table 3 .
The countries with the 6 highest values of AMC (Mozambique, Nigeria, Mali, Somalia, Malawi, and Burundi) were all among the 10 countries with the highest estimates of maternal deaths from breast or cervical cancer. For RMC, the highest associated value predicted by the proposed model was approximately 30% for Niger, indicating that, for every 100 women who died from breast or cervical cancer in Niger, an estimated 30 children would die. Even with a more conservative assumption of an EMRR of 3.0, the RMC remained above 10% for the African nations with the 10 highest RMC values (Niger, Chad, Equatorial Guinea, Somalia, Sierra Leone, Nigeria, Cote D'Ivoire, Central African Republic, Burundi, and Angola). Eight of the 10 countries with the highest RMC values were among the top 10 African countries for either fertility or baseline child mortality.
A map of African nations with each nation's projected RMC is provided in Figure 3 . Geographically, lower relative contributions to overall breast and cervical cancer mortality when including associated child deaths are projected for Northern Africa, including Egypt, Algeria, Tunisia, Morocco, Libya, and the Southwestern region of the continent, particularly Namibia and Botswana. Higher RMCs are projected for Western and Central Africa.
DISCUSSION
We developed a model to estimate the impact of a woman's death from breast and cervical cancer on child mortality, because neoplasms account for the highest contributors to mortality for women of childbearing age and, globally, these are the 2 most common cancers in women of reproductive age. 11, 12 Conservative estimates in the benchmark analysis predicted a relative contribution to overall Poisson distributions generated upper and lower bounds for sensitivity analyses. Rates of child mortality, breast cancer mortality, cervical cancer mortality, and fertility were evaluated using age-specific bounds, as listed in Supporting Table 2 .
Cancer January 1, 2019 cervical and breast cancer mortality as high as 14%; for instance, in Burkina Faso, for every 100 women who die from breast or cervical cancer, 14 children would die. Extended analyses for the remaining 53 African countries predicted that, for every 100 women who die from breast or cervical cancer, from 14 to 30 children would die as a result. We also evaluated the factors that may increase the impact from the association between a mother's death from breast and cervical cancer and her child's death in sensitivity analyses. The AMC to childhood deaths was particularly influenced by mothers' breast and cervical cancer mortality, as expected; conversely, the RMC to childhood deaths from mother's deaths of breast and cervical cancer (which reflects an underestimation of the impact of breast and cervical cancer) remained wholly stable in the sensitivity analysis for Bangladesh and for the most part when evaluating Burkina Faso, except for the influence of EMRR. This contrast is a result of the large confidence interval observed for the EMRR for Burkina Faso and underscores how greater investigation into the correlation between mother and child mortality is needed.
Despite the growing body of evidence associating a mother's death with a child's death, to our knowledge, there has been no formal effort to calibrate or quantify this relation. Such an effort would be helpful to inform cohesive health policies and interventions to address this association. We propose a model-based tool to estimate the disease burden comprehensively, including the associated death of offspring. In accounting for this relation, we used a multiplier (the EMRR) to capture the elevation in mortality experienced by children whose mothers have died compared with children whose mothers are alive in a specific country.
Because many African nations are experiencing rapid economic development, many similarly face a rapid rise in noncommunicable diseases alongside the unfinished agenda of the MDGs. A majority of African countries Cancer January 1, 2019 are indexed with a low Human Development Index, for which the combined incidence burden of breast and cervical cancer represents one-third of the total cancer burden in women. 24 Cohort studies illustrate that children who have lost their mothers die from the same causes as children whose mothers remain alive. 5, 6 Defining the direct effect of breast and cervical cancer mortality on the life expectancy of offspring enables a more accurate measure of the burden associated with these diseases. We assume that the children of mothers who have died from these 2 cancers will face their country-specific child mortality risk after the mother's loss, defined by a country-specific EMRR. It is probable that countries with higher baseline child mortality will have higher EMRR values. On the basis of this assumption, Sierra Leone, the African country with the highest child mortality, would have an RMC of 27%. Preventing 4 mothers from dying of breast and cervical cancers could save 1 child's life. Moreover, because we capped the EMRR values in the model from the few data that exist, it is possible and probable that the results presented tend to underestimate the real burden.
There were several limitations to the current study. The model assumed no relation between birth order or birth timing on maternal fertility or sibling mortality, as indicated in the Supporting Materials. This means that having had a child did not impact a woman's chance of giving birth as the model progressed and that children with siblings faced the same rate of mortality as children without siblings. Like in any model, ours is limited in the quality of the data used. Hence, its results should be interpreted cautiously. For instance, a clear limitation of the United Nations World Population Prospects as a source for baseline mortality risk is that it encompasses all children and children without mothers. Because children with living mothers significantly outnumber children with deceased mothers, we considered this an acceptable approximation; however, in areas where mothers' mortality is higher, the model may overestimate the results. Reflecting on data quality and the recent publication of the 2016 Global Burden of Disease study, with a data-quality maximum of 5 stars, apart from Egypt's rating of 3 stars, the remaining countries on the African continent had quality scores of 2 stars or less. 12 The findings from our model for the exploratory analysis of African countries should be heeded with this quality metric in mind and also with regard to the data obtained from Cancer January 1, 2019 Globocan in countries without national cancer registries. This analysis was limited to assessing the impact of breast and cervical cancer death on children's deaths and did not include an investigation of the impact of disability or comorbidity during a mother's life with the disease. We used death (and not incidence) as the endpoint to maintain scientific integrity and correctly apply the mortality rate ratios, because cohort studies associating child mortality with mothers' mortality have used death, and not overall disability or ill health, as an endpoint. 6, 7, 10 Even so, data for the human immunodeficiency virus-positive population in Uganda indicate that a mother having human immunodeficiency virus impacts child mortality apart from child seropositivity, 25 but similar data are lacking for other diseases. It has been demonstrated using disability-adjusted life-years (a composite measure capturing years of life lost and life-years spent with disability) that women survivors of breast and cervical cancer experience a substantial number of life-years lived with disability. 24 More investigation is needed to understand the effect of a mother's disease and disability on child mortality. Ideally, the model's projections should be validated in another data set, yet the paucity of data from the countries for which we project these estimates does not allow for validation, emphasizing the need for further evaluation of this association.
Because studies addressing the association between mother and child mortality have been observational in nature, it is important to note that a causal relation (and the reason thereof) between mother and child remains to be determined, and we hope the current work calls further attention to exploring it. Our work builds on studies that have established statistically significant relations between mother and child mortality controlling for confounding with multivariate models. Although these works evaluate and note the significance of maternal mortality on child mortality adjusting for the factors described above, in fact, the associations may have an interaction effect with some of the variables, such as socioeconomic status or other social determinants of health. It is probable that the deaths from malnutrition observed among individuals from Bangladesh and Burkina are exacerbated by mothers' deaths because of loss of breastfeeding and reduced child care, but such an effect would not be expected in the 3 Nordic countries of Finland, Sweden, and Denmark. It is possible that, in certain contexts, the association between mothers' death from cancer and child mortality may vary, because the stigma associated with malignancy may have a negative impact on orphaned children. With longer follow-up (as in the study of the 3 Nordic countries), parental deaths from suicide and mental illness were associated not only with child mortality in general but also from offspring dying of the same cause (from neoplasm). Obviously, further research is needed to explore the intricate and sociocultural nature of the correlation between mother and child death.
The impact of a mother's survivorship on child survival has been demonstrated as a global phenomenon, and the recently published series in The Lancet on women's cancers similarly noted this association, highlighting a paucity of publications addressing the impact of a woman's death from cancer on her child's survival. 24 Although it may be subject to the inevitable uncertainties of a model, with results to be carefully interpreted, the proposed predictive analysis is a starting point. It is meant to stimulate problem-solving that reaches solutions and to represent accurately and more comprehensively the mortality burden from cancers diagnosed in women worldwide.
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